CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us
  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Biotech Companies in APAC Top BioTech Companies in China - 2024 Top BioTech Companies in Japan - 2024 Top Biotech Company In Apac - 2024 top biotech companies in apac - 2021

Life Sciences Review

BioTech

Elevating Medical Affairs-A Strategic Imperative for General Managers

Elevating Medical Affairs-A Strategic Imperative for General Managers

Jon Zdon

Head Medical Governance, Evidence and Patient Access

Novartis, Australia & New Zealand

Biological Crown Gall Control Solutions In Apac

Turning Scientific Discovery into Biological Crown Gall Control

Gary Bullard

Owner and CEO

Bio-Care Technology

Featured Issue
PreviousNext

Featured Categories

Biological Crown Gall Control Solutions in APAC

Liposomal Technologies in Asia

#

Oncology in Transition

Sarah Tregenza, Director of Medical Affairs Oncology (APAC) Pierre Fabre Group
#

Implication of Generative AI in Biotechnology

Dae Wook Lee, Medicine (MbChB), MBA, MSC, BSc, Medical Director, Pharmaceuticals Korea, Clinical Development and Medical Affairs, Republic of Korea Novartis
#

Liposomal Technologies In Asia

Setting the Standard in Validated Liposomal Delivery System

Dr. Jianjun Yu, Director of R&D EffePharm
#

Organoids On Chips Model

Redefining Organoids-on-Chips as Decision-Grade Preclinical Infrastructure

Zhou Yu, CEO Daxiang Biotech
Clinical Trials Landscape in APAC and Its Unique Characteristics and Opportunities

Clinical Trials Landscape in APAC and Its Unique Characteristics and Opportunities

Marcia Matos, APAC Clinical Operations Hub Director,

Servier

PharmAbcine: Blazing the Trail in Antibody-Based Oncology Therapeutics

Blazing the Trail in Antibody-Based Oncology Therapeutics

Dr. Jin-San Yoo, Founder and CEO

#

A Game-Changer in Vaccine Production

Shinji Fujino, Co-Founder and CEO; Yutaka Kuroda, PhD, Co-Founder and CSO

News

Hospital-Based Stem Cell Programs Highlight the Access Challenge

Elevating Patient Care: The Impact of AI on Prognostic Testing

Evidence before Expansion in Stem Cell Therapy

Molecular Pathology Built Around Clinical Context

Immunotherapy: Unleashing the Power of the Immune System in Cancer Treatment

Immunotherapy: Unleashing the Power of the Immune System in Cancer Treatment

Clement Lim, Director, Head of Early Cancer Detection, Scientific & Medical Affairs

Mirxes

Beyond Distribution-Distributors Value in Healthcare Ecosystem

Beyond Distribution-Distributors Value in Healthcare Ecosystem

Ziteng Zhang, Senior Distribution Manager, West China (Rotation)

CSL

The Growing Potential of NGS in Agriculture

The Growing Potential of NGS in Agriculture

Mark Dupal, Vice President, Sales – APAC

Twist Bioscience

Zhuhai Trinomab Pharmaceutical Co., Ltd.: Scaling New Heights in Antibody Innovation

Scaling New Heights in Antibody Innovation

Zhao Wengui, Vice President, General Manager of Marketing of Greater China

The simple things in life are still the best, even in clinical development

The simple things in life are still the best, even in clinical development

Ken Lee, General Manager and Region Head, Clinical Development, Asia Pacific

Syneos Health

Ensuring Supply Availability Begins with Robust Supplier Quality Management

Ensuring Supply Availability Begins with Robust Supplier Quality Management

Imelda Leslie Rillon, Director, Regional Quality Assurance

ZuelligPharma

Challenges To Clinical System In China

Challenges To Clinical System In China

Cheryl Chen, Director of Clinical Operations

BeiGene

Medical Affairs Takes Centre Stage

Medical Affairs Takes Centre Stage

Dr. Sarah Tregenza, PhD, BSc (Hons), APAC Oncology Medical Affairs Director

Pierre Fabre

Loading...
#

AI-Driven Biomarker Panel Discovery

Namyong Lee, CEO

#

Pioneering 4d Bioprinting

SeokHwan You, Founder and CEO

#

Comprehensive Bioanalytical Partner for Drug Development

Dr. Linglong Zou, founder and CEO

#

Transforming Skincare through Science-Backed Solutions

Motoji Kawasaki, President and CEO

Meiji Holdings (TYO: 2269): Harnessing Food and Pharmaceutical Expertise for Health Innovations

Meiji Holdings (TYO: 2269): Harnessing Food and Pharmaceutical Expertise for Health Innovations

Dr. Masashi Nagata, General Manager of Wellness Science Labs and Toru Kawahatsu, Associate General Manager, Wellness Science Labs

Transforming Vision Care with Breakthrough Technology

Transforming Vision Care with Breakthrough Technology

Dr. Hitoshi Kusano, CEO, PharmaBio Corporation

#

Breakthrough In Adaptive Hydrogel Technology

Shin Yoshida, Co-Founder and CEO and Madoka Takai, Technical Advisor/CTO, Co-Founder

News

Research Peptide Suppliers Supporting APAC Scientific Growth

Harnessing Biotechnology for Natural Ingredient Innovation in APAC

Biological Controls Shift Crown Gall Management Upstream in APAC Nurseries

Crown Gall Prevention Becomes Part of the Nursery Buying Decision in APAC
A Versatile and Faster Way to Induce Mutagenesis

A Versatile and Faster Way to Induce Mutagenesis

Norio Kikuchi, CEO, CTO and Founder

Driving Drug Development Forward with Functional PVPs

Driving Drug Development Forward with Functional PVPs

Herb Ulmer, Chief Scientist, Ella Qu, General Manager, Boai NKY Pharmaceuticals

Emphasizing the importance of quality assurance in assuring product quality

Emphasizing the importance of quality assurance in assuring product quality

Raymond R. Tjandrawinata, Director of Business Development and Scientific Affairs, Dexa Medica

Charting A New Path In Endovascular Care

Charting A New Path In Endovascular Care

Joseph Ingrassia, Interventional Cardiologist, Director Vascular Medicine & Endovascular Intervention, Hartford Hospital

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-apac.lifesciencesreview.com